Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study.

Advances in Therapy
Javier EscaladaDirk Müller-Wieland

Abstract

Randomized controlled trials and real-world data from the USA have shown similar glycemic control with insulin glargine 300 U/ml (Gla-300) and insulin glargine 100 U/ml (Gla-100) and reduced hypoglycemia risk with Gla-300. This real-world study describes the efficacy and safety of Gla-300 and Gla-100 in patients with type 2 diabetes (T2D) in France, Spain, and Germany. This retrospective chart review analysis used anonymized data for adults with T2D switching basal insulin analog (BIA) therapy to Gla-300 or Gla-100, or insulin-naïve patients initiating Gla-300 or Gla-100. Outcomes included change from baseline to 6-month follow-up in glycated hemoglobin A1c (A1C), total and severe hypoglycemia incidences and events, insulin dose, and reasons for BIA choice. Six hundred sixty-five physicians (33.8% Spain, 31.7% France, 34.4% Germany) provided chart data for patients switching to Gla-300 (n = 679) or Gla-100 (n = 429) or initiating Gla-300 (n = 719) or Gla-100 (n = 711). After adjustment for baseline characteristics, A1C reductions from baseline were similar for patients switching to Gla-300 or Gla-100 (- 0.87% vs. - 0.93%; p = 0.326) while those switched to Gla-300 vs. Gla-100 had a significantly greater mean reduction in hypogl...Continue Reading

References

Feb 9, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotP-M Schumm-Draeger
May 29, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·A NicolucciUNKNOWN DAWN2 Study Group
Oct 5, 2016·Clinical Pharmacokinetics·Jennifer N ClementsKayce M Shealy
Dec 14, 2016·The New England Journal of Medicine·Rachel E ShermanRobert M Califf
Oct 12, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Peter Wiesli, Marcus Schories
Feb 16, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jeremy PettusLuigi Meneghini
Jul 3, 2019·Diabetes, Obesity & Metabolism·Timothy S BaileyLawrence Blonde
Nov 30, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Pierre GourdyBruno Guerci

❮ Previous
Next ❯

Software Mentioned

DISCOVER
SAS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.